Back to Search
Start Over
Galantamine shows long-term noncognitive benefits. (Clinical Notes)
- Source :
- The Brown University Geriatric Psychopharmacology Update. April, 2003, Vol. 7 Issue 4, p7, 2 p.
- Publication Year :
- 2003
-
Abstract
- A group of researchers explored the long-term benefits of galantamine (Reminyl) in 699 patients with mild-to-moderate Alzheimer's disease (AD). The study consisted of a six-and-a-half month double-blind phase followed by [...]
- Subjects :
- Galanthamine -- Dosage and administration -- Evaluation -- Physiological aspects -- Product/service Evaluations
Alzheimer's disease -- Drug therapy -- Development and progression -- Physiological aspects
Health
Psychology and mental health
Seniors
Razadyne (Medication) -- Evaluation -- Product/service Evaluations
Subjects
Details
- Language :
- English
- ISSN :
- 15292584
- Volume :
- 7
- Issue :
- 4
- Database :
- Gale General OneFile
- Journal :
- The Brown University Geriatric Psychopharmacology Update
- Publication Type :
- News
- Accession number :
- edsgcl.100878986